Conexeu Sciences Inc.

Biotech Reno, NV

About

Issuer

Entity type
Corporation
Jurisdiction
Nevada
Sector
Biotech
Headquarters
Reno, NV
Street
50 West Liberty Street, Suite 880
Zip
89501

Offering

Total offering
$1.8M
Amount sold
$1.8M
First sale
Mar 25, 2026
Min investment
$0
Securities
Equity
Federal exemption
Rule 506(b)
Investors so far
8

How this filing compares

Ranked #28 of 47 Biotech filings in April 2026 by offering amount.

Median Biotech filing in April 2026: $3M. This offering is 0.6× the median.

Other Nevada filings this week: Stable Group Investments LP, PFD GLOBAL HOLDINGS, LLC, Planck Holdings LLC - Series 2023Y, Dream SPV VA 2 LLC, Guac I, a series of Capitalize Investments LLC

Leadership

DAVID R BOGART — Director

MILES HARRISON — Executive Officer (also: Director)

AARON FARBERG — Director

STEPHEN D INOUYE — Executive Officer

CLAUDIA CHAVEZ-MUNOZ — Executive Officer

JEFF SHARPE — Director

Z PAUL LORENC — Director

SEBASTIAN PURCELL — Director

BRIAN PILCHER — Executive Officer

Filing details

Conexeu Sciences Inc. filed a Form D with the SEC on April 1, 2026.

Other newest Biotech companies

Other newest companies in Nevada